A BMI of more than 25 kg/m seems to be a protective factor for renal function deterioration in some patients….
Read More »Handbook of Diabetes, 4th Edition, Excerpt #6: Epidemiology and Aetiology of Type 2 Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Epidemiological studies of diabetes prevalence are often based upon age and self-reported diagnosis. Consequently differentiating type 1 and type 2 patients in population studies is difficult. The most recent authoritative review of global prevalence published by the International Diabetes Federation (IDF) …
Read More »New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Beta cell encapsulation therapy is a procedure that involves implantation of cells with the ability to secrete insulin in a glucose-responsive manner in a protective barrier into the body…. On July 17th 2014, the Juvenile Diabetes Research Foundation (JDRF) announced that their partner, ViaCyte, Inc. filed an Investigational New Drug …
Read More »Acarbose Treatment and the Reduction of CVD Risk in Type 2 Diabetes Patients
Previous studies have shown that decreasing postprandial hyperglycemia with acarbose could reduce the risk of CV events but a new study shows that risk may increase for the first 12 months of exposure….
Read More »Gender Differences in Control of Multiple CVD Risk Factors in Type 2 Diabetes Patients
Adjusted mean DBP levels found to be significantly higher in women compared to men but other risk factors were almost the same between genders….
Read More »Hypoglycemia Awareness improves with Self-Monitoring in Type 1 Diabetes
The best outcomes were achieved by multiple daily injections with self-monitoring of blood glucose….
Read More »Safe and Effective Closed Loop Insulin Delivery for Type 1’s Decreases Hypo’s
A new delivery system has been evaluated and found to be safe and effective for young adults to use at home without any supervision needed….
Read More »New Way to Regenerate Beta Cells in Type 1 Diabetes Patients
A peptide called caerulein converted existing cells in the pancreas into insulin-generating beta cells….
Read More »Handbook of Diabetes, 4th Edition, Excerpt #5: Epidemiology and aetiology of type 1 diabetes
Rudy Bilous MD, FRCP Richard Donnelly MD, PHD, FRCP, FRACP The most common cause of type 1 diabetes (over 90% of cases) is T cell-mediated autoimmune destruction of the islet beta cells leading to a failure of insulin production. The exact aetiology is complex and still imperfectly understood. However, it …
Read More »Stanley Schwartz, MD: Classifying Diabetes Types, ADA 2014, Part 1
In this week’s Homerun Slides, we begin a series which Dr. Stanley Schwartz presented at the 2014 ADA Scientific Sessions, where he outlined some of the problems with the current diabetes classification system. This first section discusses the definition of LADA and shows how diabetes diagnosis characteristics frequently overlap….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.